This study focuses on analyzing retrospectively the data about the medication of statins, antiplatelet therapy and renin-angiotensin blocker in elderly coronary artery disease (CAD) patients complicated with renal insufficiency, the risk factors of renal prognosis and mortality. This evidence concerns the gene REN and coronary artery disorder.